We attempted to induce experimental arthritis in rats by systematically testing the effect of Yersinia infections in five strains of rats, using the intragastric, intraperitoneal, and intravenous routes of inoculation. We observed that Lewis rats which were given 104 to 105 Yersinia enterocolitica WA organisms via the intravenous route consistently developed arthritis. The arthritis was most severe at 3 weeks and subsided at 6 weeks. No arthritis was observed when this bacterial strain was administered to Buffalo, Fisher, DA, and LDA rats. No replicable bacteria were detected in the joints. This aseptic characteristic parallels that seen in the human condition and establishes this as an animal model of Yersinia-induced arthritis. The probable reason for arthritis development in only the Lewis rats became apparent when we analyzed the numbers of live bacteria in the spleens and livers of these infected animals. The arthritis-susceptible Lewis rats harbored 10-fold more bacteria than the arthritis-resistant rat strains, and this systemic infection also persisted for a significantly longer period. Speculations as to why human subjects who develop Yersinia-induced arthritis are genetically predisposed have been centered principally around the role of the HLA-B27 histocompatibility antigens. The present study reveals a heretofore unrecognized critical factor: the susceptibility of the hosts to the virulence of the infectious organisms. In addition, the present animal model will provide the necessary tool for the investigation of this and other important host and bacterial factors.
Reactive arthritis in humans is characterized by two major features. First, in each patient, the development of arthritis is preceded by an episode of infection by one of several organisms. These include Shigella flexneri, Salmonella typhimurium, Campylobacterjejuni, and Yersinia enterocolitica (1, 2, 8, 10, 11) . The arthritis is termed reactive rather than infective because the infectious organisms cannot be recovered from the arthritis tissues. The second feature is that the majority of the patients have the HLA typing of HLA-B27, indicating a very strong genetic predisposition to the development of arthritis (reviewed in reference 7) .
Despite this information, it is not clear how the genetic factors affect the host-bacterial reactions to promote the development of arthritis. As in the investigation of many other diseases, the availability of an animal model might be crucial. Our study was prompted by personal communication from Philip B. Carter (Chapel Hills, Raleigh, N.C.) that some rats in his laboratory were fortuitously observed to develop arthritis after infection with the Y. enterocolitica strain designated as WA. Y. enterocolitica organisms having the same serotype as this WA strain have been reported to cause arthritis in humans (6) . This particular strain of Y. enterocolitica, the WA strain, can also cause potentially lethal infections in rats and mice (3) . In our initial experiments, graded doses of the bacteria were given to five individual strains of rats to determine the sublethal bacterial doses they could tolerate as well as the frequency of arthritis. To ensure adequate access of the organisms into the bloodstream, the intravenous route was selected. We found that a severe arthritis consistently appeared in one of the five strains of rats tested. Subsequent experiments were directed at the following two questions: (i) whether this was a reactive or an infective arthritis, and (ii) whether there was a measurable parameter of host-bacterial interaction which Six Lewis rats were also given iOs bacteria.
All of them survived at day 14. induced arthritis is relatively rare. It was chosen for our study because it is virulent when tested by the in vivo lethality test in mice. All four strains of bacteria were passaged in our laboratory in Swiss Webster mice (Jackson Laboratory, Bar Harbor, Maine) and preserved at -70°C in 50% glycerol. Before an experiment, a sample of each bacterial strain was recovered by being cultured at room temperature on tryptic soy agar plates (Difco Laboratories, Detroit, Mich.). Plasmid-positive colonies of these Yersinia bacteria were selected both by their colony appearance on agar plates and by their autoagglutinating property (9) . Further cultures were carried out in tryptic soy broth to late-log phase at room temperature. After the cultures were washed with phosphate-buffered saline, 0.2-ml aliquots were injected intravenously into the rats. Bacterial concentrations were estimated by spectrophotometry prior to injection into the rats. A colony count of the sample was carried out the next day when the colonies first became visible. These counts were within the range of 0.5 to 5.0 times the values estimated by spectrophotometry. For simplicity, only the values estimated by spectrophotometry are shown in this paper.
Irradiation of bacteria. Y. enterocolitica WA organisms were cultured and harvested as described above. The sample was then irradiated with 7,000 rad (model Gammator M; Gammatron, N.Y.). This irradiation dose was decided from the results of an experiment in which the bacteria were treated with graded doses of irradiation. A dose of 7,000 rad was the minimum necessary to completely inhibit the growth of this bacterial strain on agar plates.
Measurement of the number of bacteria in rat tissues. After the rats were sacrificed, the spleens and livers were dissected. enterocolitica WA has been reported to be potentially lethal to rats (3) . In our first experiment, graded doses of bacteria were injected intravenously into five strains of rats. A dose of 108 Yersinia organisms proved to be lethal for all five strains of rats, with no survival 5 days after inoculation and no apparent differences among the strains. The rates of survival on day 14 after inoculation with lower doses are compared in Table 1 . The Lewis rats appeared to be the most susceptible. None of the six Lewis rats given 106 bacteria survived at day 14. They died at day 10.5 ± 2.2. The other four strains of rats, on the other hand, survived for this period when given the same number of bacteria. The results presented in Table 1 are pooled from two separate experiments. In each experiment, all five strains of rats were tested simultaneously. Although data are presented in Table 1 as survival through day 14, all surviving rats were observed further and were found to survive until sacrifice at 4 to 6 weeks. The sublethal doses tolerated by each individual rat strain were used for the remainder of the experiments.
Incidence of arthritis. Rats which were given the sublethal doses shown in Table 1 were observed for a total of 6 weeks for signs of arthritis. Arthritis was regarded as being present when the hind-paw volumes exceeded 3 plethysmograph units. The incidence of arthritis in each rat strain is shown in bacteria per rat. A dose of 106 bacteria per rat was lethal. While Lewis rats showed a 100% incidence of arthritis, Buffalo, Fisher, DA, and LDA rats were negative at doses of 104 to-106 bacteria per rat. All four paws of some of the Lewis rats appeared swollen. However, in all the Lewis rats, the most severe arthritis was generally at the hind paws. Soft-tissue swelling and pain were most obvious, as was erythema. No consistent lesions were observed in the eyes, genitals, skin, or tails. Raising the Lewis rats pathogen free did not affect their susceptibility to arthritis.
Course of arthritis. The course of arthritis was closely monitored in 12 Lewis rats. Plethysmograph measurements of hind paws were recorded at weekly intervals for a total of 6 weeks. A mild arthritis was observed 1 week after injection; the mean plethysmograph value was 10.4 ± 3.2. Maximum arthritis was observed at week 3; the mean plethysmograph value was 78.2 ± 7.8 (P < 0.005 compared with value at week 1). At week 6, the arthritis had regressed and the plethysmograph value became 6.7 + 2.5. Eight rats which were given only intravenous phosphate-buffered saline were observed in parallel. No arthritis appeared in these control rats ( Fig. 1 and 2) .
Histological sections were prepared from the knee and ankle areas from both control rats and rats at the height of arthritis. The appearance of a normal knee joint is compared with that of an arthritic knee joint and an arthritic ankle joint in Fig. 3 (Fig. 4) . The values in the Lewis rats at days 7 and 21 were significantly higher than those in each group of the nonLewis rats (P < 0.0005 and P < 0.05, respectively). The numbers of viable bacteria recovered at day 21 from the groups given intragastric and intraperitoneal inoculation were drastically different. No bacteria were recovered from the spleens and livers of the group given intragastric inoculation. The numbers of CFU recovered from the spleens of the six rats given intraperitoneal inoculation were, 0, 1. (Table 4) . These rats were then observed for 6 weeks. None of them developed arthritis.
In a parallel experiment, an additional three rats inoculated with the non-WA bacterial strains were sacrificed at day 7 after injection to enumerate the bacterial CFU in their spleens. Their values are almost 100-to 1,000-fold less than those of a group of five WA-inoculated Lewis rats assayed in parallel (P < 0.0025 when the WA-inoculated Lewis group is compared with each of the non-WA-inoculated Lewis group). DISCUSSION The mechanism of Yersinia-induced arthritis is an enigma. This is so, although multiple strains of arthritis-causing bacteria have been isolated (1, 2, 8, 10, 11 ), large numbers of patients have been recruited for study, and the major genetic factor causing predisposition to arthritis has been identified (7). Some critical questions remain unclear, such as whether the development of arthritis requires prolonged persistence of the bacteria in the hosts and whether any discrete bacterial components home to the joint tissues. It would be almost impossible to answer such questions concerning in vivo events unless an experimental animal model were available. The major objective of the project described in this paper was to establish such a model.
Through a systematic analysis of several variables, we have verified the personal communication from P. B. Carter that such a model is indeed possible. Three experimental factors are critical. They include the Yersinia strain, the type of rats, and the route of bacterial administration. The route has to be intravenous or intraperitoneal but not peroral. This was unexpected, because the human condition is induced by gastroenteritis. Perhaps the mucosal defense in the rat species is more effective in preventing access of the Yersinia organisms from the bowel to the general circulation.
Our arthritis model would be quite meaningless if viability of the Yersinia strains was not necessary, if coinfection with other organisms was needed, or if, unlike the situation with patients, viable bacteria could have been recovered from the joints. However, irradiation of the bacteria eliminated both their ability to replicate and their ability to induce arthritis. Lewis rats which were apparently pathogen free could also develop Yersinia-induced arthritis. Lastly, when the joints from 15 infected animals were examined, no colony-forming bacteria could be cultured.
The clinical value of our findings depends largely on whether the mechanisms of Yersinia-induced arthritis in the Lewis rats are the same as those in humans. This remains to be proven. If such proves to be the case, our results are potentially interesting in that they allow us to assess the role contributed by the virulence of the bacteria and also the susceptibility of the hosts to this virulence. These two factors have not heretofore been suspected to be important when the human condition was being investigated. The interpretation of our results becomes quite straightforward if one assumes that Y. enterocolitica WA can consistently induce arthritis in the Lewis rats because they carry discrete arthritis-causing components. There can then be two possible explanations of why arthritis did not develop in our Buffalo, Fisher, DA, and LDA strains. The first possibility is that in these arthritis-resistant rats, the putative arthritiscausing Yersinia components cannot initiate the cellular or Table  4 . When we administered 106 of each of these bacterial strains to the Lewis rats, the numbers of bacteria which were recovered in the spleens 1 week afterwards were at least 100-fold lower than those in the arthritis-causing Y. enterocolitica WA. This again indicates that a relative lack of virulence is associated with failure to induce arthritis.
In summary, we postulate from our findings that two aspects are important in reactive arthritis: whether the bacteria carry potentially arthritis-causing components and whether the infected hosts are highly susceptible to the infection. The latter, in turn, depends on both the inherent virulence of the bacteria and on the genetic susceptibility of the hosts. The availability of this animal model will allow investigators to examine the host genetic factors in detail.
The host immune response to the potentially arthritiscausing bacterial component(s) could prove to be an area of extreme interest in this animal model. In other animal models of arthritis, experiments involving transfer of serum (12) or cells (14) of arthritic rats has established a role for both the humoral and cellular compartments of the immune system. In the clinically relevant animal model described herein, the sera and cells of rats with Yersinia-induced arthritis could prove to be most valuable reagents in the investigation of pathogenetic mechanisms.
The major weakness of our hypothesis is that none of our results directly supports the idea that the putative arthritiscausing components can induce arthritis in the non-Lewis rats, even when given in large quantities. One can argue, perhaps, that this postulate would explain why considerable numbers of patients with reactive arthritis are HLA-B27 negative and do not have any apparent genetic predisposition (7) . However, the actual testing of this hypothesis must await the identification of those particular bacterial components. Very importantly, the animal model provides a valuable tool for investigators to identify these arthritis-causing components and perhaps even their structural prerequisites. This has been the case in peptidoglycan-induced arthritis (5) as well as adjuvant-induced arthritis (4), two models in which the clinical relevance to human disease is much less certain than the Yersinia-induced arthritis model.
